Table of contents

Research Article

• Psychological factors in gastro-oesophageal reflux disease. (1 April, 1995)

  B T Johnston, S A Lewis, A H Love
• Acute gastrointestinal haemorrhage in patients treated with anticoagulant drugs. (1 April, 1995)

  C P Choudari, K R Palmer
• Role of biliary stenting in the management of bile duct stones in the elderly. (1 April, 1995)

  H R Dalton, R W Chapman
• Rising death rate from non-malignant disease of the oesophagus (NMOD) in England and Wales. (1 April, 1995)

  M Z Panos, R P Walt, C Stevenson, M J Langman
• Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group. (1 April, 1995)

  C M Bate, S N Booth, J P Crowe, R A Mountford, P W Keeling, B Hepworth-Jones, M D Taylor, P D Richardson
• Integrity and characteristics of secondary oesophageal peristalsis in patients with gastro-oesophageal reflux disease. (1 April, 1995)

  M N Schoeman, R H Holloway
• Precipitating causes of acid reflux episodes in ambulant patients with gastro-oesophageal reflux disease. (1 April, 1995)

  C P Barham, D C Gotley, A Mills, D Alderson
• Misoprostol inhibits gastric mucosal release of endogenous prostaglandin E2 and thromboxane B2 in healthy volunteers. (1 April, 1995)

  A Mertz-Nielsen, O Eskerod, K Bukhave, J Rask-Madsen
• Cytophotometric and flow cytometric DNA content of isolated glands in gastric neoplasia. (1 April, 1995)

  Y Kitayama, S Nakamura, H Sugimura, I Kino
• Accelerated gastric epithelial proliferation. (1 April, 1995)

  M R Gray, S J Darnton, J A Hunt, R W Irlam, J Nemeth, H M Wallace
• Muscarinic M1 receptor inhibition reduces gastroduodenal bicarbonate secretion and promotes gastric prostaglandin E2 synthesis in healthy volunteers. (1 April, 1995)

  A Mertz-Nielsen, J Hillingsø, O Eskerod, K Bukhave, J Rask-Madsen
• A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. (1 April, 1995)

  E el-Omar, I Penman, J E Ardill, K E McColl
• Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. (1 April, 1995)

  E F Verdú, D Armstrong, R Fraser, F Viani, J P Idström, C Cederberg, A L Blum
• Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. (1 April, 1995)

  J A Louw, W Lucke, K Jaskiewicz, A J Lastovica, T A Winter, I N Marks
• Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells. (1 April, 1995)

  T Mothes, U Bendix, C Pfannschmidt, I Lehmann
• Role of 5-hydroxytryptamine in intestinal water and electrolyte movement during gut anaphylaxis. (1 April, 1995)

  F H Mourad, L J O'Donnell, E Ogutu, J A Dias, M J Farthing
• Effect of gonadectomy on epidermal growth factor values in the gastrointestinal tract of male and female CD-1 mice. (1 April, 1995)

  M Sayegh, J B Elder
• Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. (1 April, 1995)

  J Lewin, A P Dhillon, R Sim, G Mazure, R E Pounder, A J Wakefield
• Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. (1 April, 1995)

  H H Tsai, A D Dwarakanath, C A Hart, J D Milton, J M Rhodes
• Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's strictures: a prospective longterm analysis. (1 April, 1995)

  H Couckuyt, A M Gevers, G Coremans, M Hiele, P Rutgeerts
• Hereditary proctalgia fugax and constipation: report of a second family. (1 April, 1995)

  A F Celik, P Katsinelos, N W Read, M I Khan, T C Donnelly
• Scintigraphic measurement of ileocaecal transit in irritable bowel syndrome and chronic idiopathic constipation. (1 April, 1995)

  R Hutchinson, A Notghi, N B Smith, L K Harding, D Kumar
• Colorectal cancer screening in asymptomatic populations. (1 April, 1995)

  A R Hart, A C Wicks, J F Mayberry
• Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon alpha. (1 April, 1995)

  K T Nouri-Aria, J Koskinas, C J Tibbs, B C Portmann, R Williams
• Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. (1 April, 1995)

  S Bloom, K Fleming, R Chapman
• Octreotide, the reticuloendothelial system, and experimental liver tumour. (1 April, 1995)

  N Davies, H Kynaston, J Yates, B A Taylor, S A Jenkins
• Prevalence and pattern of familial disease in primary biliary cirrhosis. (1 April, 1995)

  A M Brind, G P Bray, B C Portmann, R Williams
• A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. (1 April, 1995)

  S O'Brien, A R Hatfield, P I Craig, S P Williams
• Purification and assay of secretory lithostathine in human pancreatic juice by fast protein liquid chromatography. (1 April, 1995)

  A Mariani, G Mezzi, A Malesci
• Quantification of human lithostathine by high performance liquid chromatography. (1 April, 1995)

  J P Bernard, M Barthet, B Gharib, R Michel, A Lilova, J Sahel, J C Dagorn, M De Reggi
• European cooperation in gastroenterology. (1 April, 1995)

  C Arvanitakis